Battle Of The Weight-Loss Pills Continues With A Shocking Twist - Investor's Business Daily

Eli Lilly stock skidded early Friday as Novo Nordisk's oral Wegovy continued to outpace Lilly's new obesity pill, Foundayo.

You will be redirected in 10 seconds.